Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,000 | 3,600 | 0 | 7,500 | 0 |
| Gross Profit | 1,000 | 3,600 | N/A | 7,500 | N/A |
| Operating Expenses | 140,159 | 132,542 | 157,135 | 153,622 | 117,950 |
| Operating Income | -139,159 | -128,942 | -157,135 | -146,122 | -117,950 |
| Other Income | 8,232 | 5,748 | 2,673 | 582 | 1,557 |
| Pre-tax Income | -130,927 | -123,194 | -154,462 | -145,540 | -116,393 |
| Income Tax | N/A | -1,078 | 74 | N/A | 1,114 |
| Net Income Continuous | -130,927 | -122,116 | -154,536 | -145,540 | -117,507 |
| Net Income | $-130,927 | $-122,116 | $-154,536 | $-145,540 | $-117,507 |
| EPS Basic Total Ops | -6.62 | -12.11 | -15.60 | -14.80 | -13.80 |
| EPS Basic Continuous Ops | -6.62 | -12.11 | -15.57 | -14.85 | -13.80 |
| EPS Diluted Total Ops | -6.62 | -12.11 | -15.60 | -14.80 | -13.80 |
| EPS Diluted Continuous Ops | -6.62 | -12.11 | -15.57 | -14.85 | -13.80 |
| EPS Diluted Before Non-Recurring Items | -6.62 | -11.60 | -15.60 | -14.80 | -13.80 |
| EBITDA(a) | $-137,413 | $-125,233 | $-151,487 | $-135,988 | $-113,271 |